Home  >  Products  >  GZMA (granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)) Blocking Peptide (the C terminal of GZMA)(100ug)
GZMA (granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)) Blocking Peptide (the C terminal of GZMA)(100ug)

GZMA (granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)) Blocking Peptide (the C terminal of GZMA)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-GZMA Antibody(ARP54794_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP54794
Size: 100ug
Weight: 26kDa
Gene: 3001
Format: Lyophilized powder
Target: Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein described here is a T cell- and natural killer cell-specific serine protease that may function as a common component necessary for lysis of target cells by cytotoxic T lymphocytes and natural killer cells.
Alternative names: CTLA3; HFSP
See Full Product Listings >